Find a Tender
complete
Official procurement procedure
The Supply, Delivery and Maintenance of a Live Cell Imaging Instrument
Laboratory
optical and precision equipments (excl. glasses)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "The Supply, Delivery and Maintenance of a Live Cell Imaging Instrument". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Medicines Discovery Catapult | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
3.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 8 active published awards; 6 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 Dec 2021, 12:22 GMT | Last source update1 Dec 2021, 12:22 GMT | Recurring procurementNot published |
ClassificationLaboratory, optical and precision equipments (excl. glasses) | ||
Delivery area | ||
OCIDocds-h6vhtk-02fbd7 | ||
What is being bought
The supply, delivery and maintenance of a Live Cell Imager.
What changed
From the official release history
- Status changed to complete
1 Dec 2021, 12:22 GMT - Official notice release published
1 Dec 2021, 12:22 GMT - Buyer information updated
1 Dec 2021, 12:22 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedThe supply, delivery and maintenance of a Live Cell Imager for the TRFID facility (cat 3 laboratories) for Medicines Discovery Catapult located in Alderley Park.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
1 Dec 2021, 12:22 GMT - Award active
Not published · Not published - Contract active
Signed 30 Nov 2021, 00:00 GMT · £150,000
Commercial outcome and competition
Awards Sartorius UK Limited Not published · Not published · active |
Contracts Contract £150,000 · signed 30 Nov 2021, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Medicines Discovery Catapult
Contracting authority GB-FTS-1022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleLive cell imaging (and analysis) capability with the following specifications is required for the CAT 3 lab facility for the Medicines Discovery Catapult:
• Both phase and fluorescence image capture in both 2D (Eg. proliferation, cell viability assays) and 3D (Eg. organoid) cell models enables the wide range of assays required to be run.
• Capacity to image multiple plates (using different protocols) at the same time, this is due to the flexibility required as the MDC works on various / multiple projects and needs this level of flexibility to efficiently perform the required experiments. The ability to simultaneously run different assays measuring unrelated endpoints is required to increase lab capacity, reducing time by running concurrent experiments.
• Automation of imaging and remote access to live experiments is required to reduce scientist time in the CAT 3 laboratory which is required from a Health and Safety perspective and also a resource perceptive from the vetting of staff required to access the CAT 3 facilities. This is a safety aspect required for a containment level 3 laboratory and makes continuous 24 hour timepoints more manageable.
• In addition to microtiter plates the instrument must be compatible with a selection of tissue culture plastics and microscope slides.
• Space is limited in the TRFID /CAT 3 facility and means that the instrument must have a compact footprint, either a benchtop instrument or the size of a standard cell culture incubator.
The Incucyte SX5 live- cell analysis system is the only system on the market that fulfils all of these requirements thus competition is absent for technical reasons and this purchase is being processed under sole source.
MDC will undertake a 10 day standstill period. If no challenges are received during the standstill period the MDC will continue to award the contract to Sartorius. The standstill period will end at midnight on Monday 13th December 2021. |